Bard 3D Mesh Left large, 4 x 6 cm, Polypropylene (PP)

Bard® 3DMax™ Mesh was developed based on careful and precise anatomical research of the inguinal canal. The three-dimensional, anatomically curved shape, sealed edge and medial orientation marker allow for easier positioning than a conventional flat mesh and also enhance the speed and simplicity of placement. About the Company Legal Status of Firm: Limited Company Number of Employees: Upto 10 People Annual Turnover: 5 - 25 Cr company-description: AXON Medical Solutions is an established supplier of advanced and latest Surgical Equipment, Instruments, Devices and Consumables. The company has created a niche in Laparoscopic Surgery, Open Surgery, Endoscopic Surgery, Bariatric Surgery, Onco Surgery, Gynaecology Surgery etc over a period of time since 2006 by adopting high standards of Customer Service and Value for Money. AXON is well known name in India Subcontinent Healthcare segment and has more than 1500 customers base which includes Hospitals, Nursing Homes, Clinic and individual Doctors. We approach our customer with a professional yet personal services that make buying our products seamless, hassle free experience for them. The entire team relentlessly aim to ensure that all healthcare professionals have access to the world class, best quality, most reliable and cost effective surgical equipment, instruments, consumables which enables them to deliver the best care to all their patients. AXON has distribution and after sales services support network in India, Sri Lanka, Nepal and Bangladesh. Some of our leading brands are REACH, SOUNDREACH, ENDO REACH, CIRCUMSURE, LIGASKIN, ENDO REACH, Allurion, iREACH MAGNUM, ENDO SRC, ENDO III etc. which are well known and established in the industry into respective domains. "Quality matters as we treasure life" hence our all products comply to any or multiple global medical device quality standards CE, FDA, ISO13485. "Innovation for life" is what AXON believes in. We collaborate with physicians, global innovators, manufacturers to identify unmet clinical needs and develop revolutionary therapies. We encourage research and academic collaborations and remain available to interact on exciting opportunities